电子邮件 | ema***@***.com | 获取Email |
---|
电子邮件 | ema***@***.com | 获取Email |
---|
Kamada is focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins. AAT is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties. The Company's flagship product is GLASSIA®, the first liquid, ready-to-use, intravenous plasma-derived AAT product approved by the U.S. Food and Drug Administration. Kamada markets GLASSIA® in the U.S. through a strategic partnership with Baxalta (now part of Shire plc) and in other counties through local distributors. In addition to GLASSIA®, Kamada has a product line of six other pharmaceutical products administered by injection or infusion, that are marketed through distributors in more than 15 countries, including Israel, Russia, Brazil, India and other countries in Latin America and Asia. Kamada's rabies immune globulin (Human) product received FDA approval for Post-Exposure Prophylaxis against rabies infection and is marketed in the U.S. through a partnership with Kedrion Biopharma. Kamada has late-stage products in development, including an inhaled formulation of AAT for the treatment of AAT deficiency and, in addition, its intravenous AAT is in development for other indications, such as type-1 diabetes, GvHD and prevention of lung transplant rejection. Kamada also leverages its expertise and presence in the plasma-derived protein therapeutics market by distributing more than 10 complementary products in Israel that are manufactured by third parties.
公司 | KAMADA |
---|---|
职位 | Director US Medical Affairs |
地点 | United States |
http://www.linkedin.com/in/winston-ally-83829142 | |
部门 | medical_health |
头衔 | Manager, Medical Affairs US |
KAMADA Director US Medical Affairs
2023-08-01 -
KAMADA Manager, Medical Affairs US
2022-08-01 - 2023-08-01
Eurofins Transplant Genomics Senior Medical Science Liaison
2021-09-01 - 2022-08-01
Eurofins Transplant Genomics Medical Science Liaison
2019-12-01 - 2021-09-01
Clinical pharmacist- Solid Organ Transplant
2019-08-01 - 2019-12-01
Winston Ally 在 KAMADA 担任 Manager, Medical Affairs US
Winston Ally 在 KAMADA 的职位是 Manager, Medical Affairs US
Winston Ally 的电子邮件地址是 ema***@***.com
Winston Ally 的电话号码是 -
Winston Ally 的公司电话号码是 +972****
Winston Ally 在 pharmaceuticals 工作。
Winston Ally 的一些同事包括Winston Ally、Avi Tedgi、Kfir Efrati、Yuval HarpazDaliya Enbar、。
Winston Ally联系方式: 电子邮件地址:ema***@***.com 电话号码:-
Winston Ally 的个人领英是:http://www.linkedin.com/in/winston-ally-83829142
Winston Ally 的办公地点:2 Holzman Street, Rehovot, Tel Aviv District, IL, 7670402
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd